FM

Frieder W. Merz

Lead Of Project Leaders Biopharma at Solvias

Frieder W. Merz, PhD has a diverse work experience in the biopharmaceutical industry and academia. From 2008 to 2008, they worked as a Research Scientist (Post Doc) at the University of Heidelberg. In 2009, they joined Molecular Partners AG in Zurich, Switzerland, where they held various roles including Scientist Assay Development, Expert Scientist, and Bioanalytics Responsible, Senior Scientist. In these positions, they were responsible for in-house research and development of assays for preclinical and clinical programs, as well as oversight of contract research organizations (CROs) and implementation of GxP-like standards. From 2011 to 2012, they served as the Lead of Project Leaders Biopharma at Solvias. Frieder W. then transitioned to become the Project Lead Biopharmaceuticals from 2016 to 2018. In 2016, they also briefly worked as a Project Manager at innovation.tank. Frieder W. Merz, PhD has extensive experience in assay development, research project management, and cross-functional team collaboration.

Frieder W. Merz, PhD has a strong education background in the field of biology. Frieder W. began their education at the University of Stuttgart, where they pursued a degree in Technische Biologie from 1995 to 2001. After completing their undergraduate studies, they went on to obtain a research position at the University of California, San Francisco in 2001. During this time, they worked as a Research Scientist and focused on their diploma thesis. Following their experience at UCSF, Frieder pursued a doctoral degree at Heidelberg University from 2002 to 2007. Frieder W. successfully completed their PhD and earned the title of Dr. rer. nat. The specific field of study for their PhD fellowship is not provided. Overall, Frieder W. Merz, PhD has extensive academic training in biology, with a diploma and a doctorate from respected universities.

Links

Timeline

  • Lead Of Project Leaders Biopharma

    April, 2018 - present

  • Project Lead Biopharmaceuticals

    September, 2016

View in org chart